Scott Leibowitz, MD
Scott Leibowitz, MD
Scott Leibowitz, MD, is an American child and adolescent psychiatrist, author, speaker, educator, and consultant who is internationally recognized for his work specializing in the care of transgender and gender-diverse (TGD) children, adolescents, and their families.
He is the President and Chief Medical Officer of Scott LeibowDr. Leibowitz was featured in The New York Times Magazine for his work as the co-lead of the Adolescent Chapter for the World Professional Association for Transgender Health (WPATH) Standards of Care, 8th Edition (SOC8). He has also served as a co-investigator on National Institute of Mental Health (NIMH)–funded research, authored more than 30 academic publications, and edited two clinical guides on pediatric gender care. In 2025, he was also featured on The New York Times podcast The Protocol, a special series exploring the history of gender care for minors.
Dr. Leibowitz completed his undergraduate pre-medical studies at Cornell University, majoring in Human Development, and received his medical degree from the Sackler School of Medicine, Tel Aviv University American Program, in 2004.
From 2008 to 2024, Dr. Leibowitz served in three academic pediatric multidisciplinary gender clinics. He first entered the field of gender care for minors at Boston Children's Hospital’s Gender Management Service, the first academic medical center program of its kind in the United States, where he also served on faculty at Harvard Medical School.
Most recently, from 2016 to 2024, he served as an Associate Professor at The Ohio State University College of Medicine and spent eight years as the Medical Director of Behavioral Health for the THRIVE Gender Program at Nationwide Children’s Hospital. During his tenure, the program became the largest embedded therapy and assessment model of any pediatric gender clinic in the United States.
In addition to his leadership role in developing the WPATH SOC8 adolescent guidelines, Dr. Leibowitz has served on the WPATH Board of Directors (2022–2026). He previously chaired the American Academy of Child and Adolescent Psychiatry’s Sexual Orientation and Gender Identity Committee from 2013 to 2021.
Dr. Leibowitz has also served as an expert witness in multiple court cases, consulted with policymakers across the political spectrum, and trained thousands of healthcare providers worldwide, including in Iceland, Israel, Japan, Norway, and Vietnam.
He is a highly sought-after keynote speaker on the ethics and complexities of pediatric gender care, bringing a unique perspective shaped by clinical leadership across multiple academic centers and experience practicing in highly charged political environments.
Dr. Leibowitz has authored more than 30 academic publications and edited two clinical guides on pediatric gender care.itz, MD LLC, a clinical, consultation, and training practice that supports TGD youth, parents, healthcare providers, and institutions that serve them.
Scott Leibowitz, MD, is an American child and adolescent psychiatrist, author, speaker, educator, and consultant who is internationally recognized for his work specializing in the care of transgender and gender-diverse (TGD) children, adolescents, and their families.
He is the President and Chief Medical Officer of Scott LeibowDr. Leibowitz was featured in The New York Times Magazine for his work as the co-lead of the Adolescent Chapter for the World Professional Association for Transgender Health (WPATH) Standards of Care, 8th Edition (SOC8). He has also served as a co-investigator on National Institute of Mental Health (NIMH)–funded research, authored more than 30 academic publications, and edited two clinical guides on pediatric gender care. In 2025, he was also featured on The New York Times podcast The Protocol, a special series exploring the history of gender care for minors.
Dr. Leibowitz completed his undergraduate pre-medical studies at Cornell University, majoring in Human Development, and received his medical degree from the Sackler School of Medicine, Tel Aviv University American Program, in 2004.
From 2008 to 2024, Dr. Leibowitz served in three academic pediatric multidisciplinary gender clinics. He first entered the field of gender care for minors at Boston Children's Hospital’s Gender Management Service, the first academic medical center program of its kind in the United States, where he also served on faculty at Harvard Medical School.
Most recently, from 2016 to 2024, he served as an Associate Professor at The Ohio State University College of Medicine and spent eight years as the Medical Director of Behavioral Health for the THRIVE Gender Program at Nationwide Children’s Hospital. During his tenure, the program became the largest embedded therapy and assessment model of any pediatric gender clinic in the United States.
In addition to his leadership role in developing the WPATH SOC8 adolescent guidelines, Dr. Leibowitz has served on the WPATH Board of Directors (2022–2026). He previously chaired the American Academy of Child and Adolescent Psychiatry’s Sexual Orientation and Gender Identity Committee from 2013 to 2021.
Dr. Leibowitz has also served as an expert witness in multiple court cases, consulted with policymakers across the political spectrum, and trained thousands of healthcare providers worldwide, including in Iceland, Israel, Japan, Norway, and Vietnam.
He is a highly sought-after keynote speaker on the ethics and complexities of pediatric gender care, bringing a unique perspective shaped by clinical leadership across multiple academic centers and experience practicing in highly charged political environments.
Dr. Leibowitz has authored more than 30 academic publications and edited two clinical guides on pediatric gender care.itz, MD LLC, a clinical, consultation, and training practice that supports TGD youth, parents, healthcare providers, and institutions that serve them.